DHART SPORE Developmental Research Program (DRP) & Career Enhancement Program (CEP) Awards support researchers studying tumors in NF1 and other inherited Rasopathy syndromes to improve diagnosis and management.
DHART SPORE DRP and CEP awards are now listed with a December 1, 2026 submission deadline. The listing includes version 3.0 guidelines for both programs.
NCI funds cancer research centers for 2027–2029 to advance prevention, detection, diagnosis, and treatment through translational research reaching a human endpoint; a clinical trial is required.
Clinical Research Award (CRA) supports researchers studying treatments, interventions, and disease management for neurofibromatosis to improve health outcomes and everyday functioning.
Drug Discovery Initiative (DDI) supports researchers testing novel or repurposed NF therapies and validating therapeutic targets to generate preliminary data and advance drug discovery.
Dermatopathology Research Career Development Award supports junior faculty with salary support for research and education that advance dermatopathology and dermatology and build academic careers.
Pilot Awards - Neuroendocrine Tumor Research Foundation support researchers' pilot and feasibility studies of neuroendocrine cancers to advance early detection, new treatments, and personalized care.